Thymalin
Thymalin is an extract of calf thymus that has been a registered immune drug in Russia since the Soviet era. It is sold abroad for immune support and longevity. The human evidence comes from the group that developed it and has not been independently repeated.
- Legal lane: registered in Russia. Not FDA-approved and not available by prescription in the US.
- Evidence grade: C. Human studies exist, but they are unblinded or single-source.
- Form: injection into muscle
- What it is: a mixture of thymus peptides, not a single molecule
What it is
A preparation of small peptides extracted from the thymus glands of calves. It was approved as a drug in the Soviet Union in 1982 for immune deficiency states. It was developed by Vladimir Khavinson and Vladimir Morozov, and it is the starting point for the family of short peptides sold as bioregulators. Two of those, Thymogen and Vilon, are single peptides identified from this extract.
What the evidence shows
The most-cited study followed 266 elderly people for six to eight years and reported lower mortality in those given thymus and pineal extracts. It was not blinded, it comes from the developers, and it has not been reproduced elsewhere in more than twenty years.
Inside Russia the drug has critics. A vice president of the Russian Society of Evidence-Based Medicine Specialists has said it was approved with very little evidence of effectiveness, and a Russian drug handbook cited by St. Petersburg journalists lists it as having no proven efficacy.
Legal status
- A registered prescription drug in Russia.
- Not approved by the FDA.
- Not eligible for pharmacy compounding in the US, according to the research summary we read, and not one of the six peptides in the October 2026 policy.
Reported dosing
We do not publish a protocol for this compound.
The Russian product has its own label, which we have not been able to check directly. The schedules on English-language sites come from sellers and enthusiast guides.
Safety
- It is an animal tissue extract. Extracts are harder to standardize than a single synthetic peptide, so two products with this name may not hold the same thing.
- What is sold internationally under this name by research suppliers is not the registered Russian product.
- No safety data of the kind the FDA requires exists.
Common questions
Is Thymalin FDA-approved?
No. It is registered in Russia only.
Is Thymalin a single peptide?
No. It is a mixture of peptides extracted from calf thymus.
Does Thymalin extend life?
One unblinded study from its developers reported lower mortality in elderly people. Nobody has repeated it.
Ask an AI about this page
Opens the assistant with a question about this page already typed in. You can edit it before sending.
Ask ChatGPTAsk ClaudeAsk Perplexity
These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.
Sources
- Molecules, 2021: history of Thymalin (1982) and Thymogen (1990) registration
- Khavinson and Morozov, 2003: the 266-person elderly cohort (PubMed)
- Paper (St. Petersburg), 2024: Khavinson's drugs and their critics in evidence-based medicine
- Rite Aid: Thymalin status and standardization cautions
- The Peptide Column: bioregulator research summary and legal status